Bridge Neurotech
Agent52Agent Readiness: 52/100. Top 25%. Measured by StartupHub.ai. Median 41.Trust78Data Trust: 78/100. Above median. Measured by StartupHub.ai. Median 61.Bridge Neurotech is building a non-invasive brain-computer interface that uses ultrasound to measure brain activity via blood flow, offering a surgery-free alternative to implanted BCIs.
About
Bridge Neurotech is a neurotechnology startup developing a non-invasive brain-computer interface (BCI) that images brain activity using functional ultrasound imaging (fUSI) and AI-based neural decoding. The company aims to provide a surgery-free and implant-free method for studying brain function and expanding human capabilities, bypassing the need for invasive neurosurgery. Their initial focus is on developing new transcranial sensing techniques and making the data useful.
Listed competitors
Key facts
At-a-glance profile data
- Website
- bridgeneurotech.com
- Headquarters
- Redwood City, United States
- Founded
- 2026
- Total funding
- $14M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 6 Oct 2026 | Seed | $14M | General Catalyst, Sunflower Capital, Scott Sandell |
Tech stack
Detected on bridgeneurotech.com, last scanned 20 Oct 2026. Run your own scan
- Analytics
- Google Analytics 4
- CDN
- Cloudflare
- Email provider
- Google Workspace
Frequently asked
Is Bridge Neurotech trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Bridge Neurotech is 78 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Bridge Neurotech raised?
Bridge Neurotech has raised a total of $14M in funding. The most recent round on record is Seed.